Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III Study

Autor: Oh, Gyu Chul, Han, Jung-Kyu, Han, Ki Hoon, Hyon, Min-Su, Doh, Joon Hyung, Kim, Moo Hyun, Jeong, Jin-Ok, Bae, Jang-Ho, Kim, Sang Hyun, Yoo, Byung-Su, Baek, Sang Hong, Rhee, Moo-Yong, Ihm, Sang-Hyun, Sung, Jung Hoon, Choi, Young Jin, Kim, Soo-Joong, Hong, Kyung-Soon, Lee, Byoung Kwon, Cho, JangHyun, Shin, Eun Seok, Rhew, Jay Young, Kim, Hyunsu, Kim, Hyo-Soo
Zdroj: In Clinical Therapeutics May 2018 40(5):676-691
Databáze: ScienceDirect
Externí odkaz: